ASX hits 3-day high led by miners, resurgent banks
Glencore preps for Queensland smelter closure. Ampol flags lower earnings. Woodside’s US hydrogen hit. Quarterly updates weigh on Telix, Paladin.
Glencore preps for Queensland smelter closure. Ampol flags lower earnings. Woodside’s US hydrogen hit. Quarterly updates weigh on Telix, Paladin.
A mid-air fire on a Virgin Australia flight has prompted an update to the airline’s policy on the carriage of power banks, to ensure they are in view at all times.
A class action against Qantas over its handling of Covid-19 travel credits will focus on what call centre staff were told to tell customers about their refund entitlements.
CBA leads bank losses, offset by gains in miners and CSL. RBA lowers chance of ‘severe’ hit to economy. Insignia’s relief rally as CC Capital’s lower-than-expected $4.80 per share offer lands.
CC Capital still keen on $3.4bn Insignia bid amid delays. ASX 200 may climb to 8700 points by December. Broker upgrade lifts Medibank to all-time high. HMC energy head out in rejigged strategy.
Widespread changes to how Aussies save and spend their money take effect today. This is what you need to know heading into the new financial year.
The ASX 200 gained 10 per cent in the financial year after with healthcare and consumer discretionary stocks driving the market higher on Monday.
Taxpayers are being warned “if they can’t substantiate it, they can’t claim it” as the end of the financial year approaches.
Domestic bourse finishes strong year despite tariff turmoil. Queen’s Wharf deal dead as Star, partners can’t resolve ‘outstanding commercial issues’. Health stocks fare best.
Tax time has arrived and a young Melbourne mum has revealed her shock after looking over her yearly earnings.
Australia’s energy minister has flagged major potential changes to the country’s domestic gas market, as the ACCC warns of looming shortfalls.
Fresh drama has engulfed the embattled Star casino group as talks over a $1.6bn Brisbane sale collapse.
A succesful business owner has revealed the tax reality that used to fill her with “anxiety” and the lesson she’s learned.
A major Aussie university and ASX-listed company will deploy psychedelic drugs to treat binge-eating in a world-first clinical trial.
Original URL: https://www.dailytelegraph.com.au/business/companies/page/16